Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darbepoetin Alfa Q4W in Anemic CRI Patients
NCT00527215Phase 2Completed
- Sponsor
- Amgen
- Start
- Mar 2002
- Primary completion
- Oct 2003
- Modality
- Erythropoietins, Colony Stimulating Factors
01
Overview
A Phase 2 trial of darbepoetin alfa in anemia, sponsored by Amgen. Started Mar 2002; status: completed.
02
Drugs
darbepoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00527215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00527215.